Clinically Relevant Dimer Interface Mutants of STAT1 Transcription Factor Exhibit Differential Gene Expression

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Staab, Julia ^a   Herrmann Lingen, Christoph ^a   Meyer, Thomas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; DNA FRAGMENT; GAMMA INTERFERON; PROTEIN TC45; STAT1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CELL METABOLISM; CELL STIMULATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CXCL10 GENE; DISEASE ASSOCIATION; ENZYME INACTIVATION; GENE; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE INTERACTION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GPB1 GENE; HUMAN; IN VITRO STUDY; IRF1 GENE; MCP1 GENE; MIG1 GENE; MOLECULAR MECHANICS; POINT MUTATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE; CELL NUCLEUS; DNA; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; NUCLEOTIDE MOTIFS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84880817370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069903     Document Type: Article

References (43)

1. Durbin JE, Hackenmiller R, Simon MC, Levy DE, (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
2. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
3. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, et al. (2003) Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19: 793-802.
4. Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, et al. (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293: 300-303.
5. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, et al. (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33: 388-391.
6. Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, et al. (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2: e131.
7. Kong XF, Ciancanelli M, Al-Hajjar S, Alsina L, Zumwalt T, et al. (2010) A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood 116: 5895-5906.
8. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, et al. (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208: 1635-1648.
9. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, et al. (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365: 54-61.
10. Smeekens SP, Plantinga TS, van de Veerdonk FL, Heinhuis B, Hoischen A, et al. (2011) STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One 6: e29248.
11. Takezaki S, Yamada M, Kato M, Park MJ, Maruyama K, et al. (2012) Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J Immunol 189: 1521-1526.
12. Sampaio EP, Bax HI, Hsu AP, Kristosturyan E, Pechacek J, et al. (2012) A novel STAT1 mutation associated with disseminated mycobacterial disease. J Clin Immunol 32: 681-689.
13. Tsumura M, Okada S, Sakai H, Yasunaga S, Ohtsubo M, et al. (2012) Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease. Hum Mutat 33: 1377-1387.
14. Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, et al. (2013) Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol 131: 1624-1634.
15. Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, et al. (2013) Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol 131: 1611-1623.
16. Darnell JE Jr, Kerr IM, Stark GR, (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
17. Darnell JE Jr, (1997) STATs and gene regulation. Science 277: 1630-1635.
18. Ihle JN, (2001) The Stat family in cytokine signaling. Curr Opin Cell Biol 13: 211-217.
19. Levy DE, Darnell JE Jr, (2002) Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
20. Sehgal PB, (2008) Paradigm shifts in the cell biology of STAT signaling. Semin Cell Dev Biol 19: 329-340.
21. Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, et al. (1995) Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2: 677-687.
22. Schindler C, Shuai K, Prezioso VR, Darnell JE Jr, (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813.
23. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr, (1992) Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258: 1808-1812.
24. Shuai K, Stark GR, Kerr IM, Darnell JE Jr, (1993) A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261: 1744-1746.
25. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, et al. (1994) Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76: 821-828.
26. Decker T, Kovarik P, Meinke A, (1997) GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17: 121-134.
27. Sekimoto T, Imamoto N, Nakajima K, Hirano T, Yoneda Y, (1997) Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J 16: 7067-7077.
28. Nardozzi J, Wenta N, Yasuhara N, Vinkemeier U, Cingolani G, (2010) Molecular basis for the recognition of phosphorylated STAT1 by importin α5. J Mol Biol 402: 83-100.
29. Meyer T, Begitt A, Lödige I, van Rossum M, Vinkemeier U, (2002) Constitutive and IFNγ-induced nuclear import of STAT1 proceed through independent pathways. EMBO J 21: 344-354.
30. Marg A, Shan Y, Meyer T, Meissner T, Brandenburg M, et al. (2004) Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J Biol Chem 165: 823-833.
31. Zhong M, Henriksen MA, Takeuchi K, Schaefer O, Liu B, et al. (2005) Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci USA 102: 3966-3971.
32. Mertens C, Zhong M, Krishnaraj R, Zou W, Chen X, et al. (2006) Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev 20: 3372-3381.
33. Wenta N, Strauss H, Meyer S, Vinkemeier U, (2008) Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Nat Acad Sci USA 105: 9238-9243.
34. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, et al. (1998) Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93: 827-839.
35. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, et al. (2005) Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 17: 761-771.
36. Müller M, Laxton C, Briscoe J, Schindler C, Improta T, et al. (1993) Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and-β signal transduction pathways. EMBO J 12: 4221-4228.
37. Begitt A, Meyer T, van Rossum M, Vinkemeier U, (2000) Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. Proc Natl Acad Sci USA 97: 10418-10423.
38. Wen Z, Zhong Z, Darnell JE Jr, (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
39. Meyer T, Hendry L, Begitt A, John S, Vinkemeier U, (2004) A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of Stat transcription factors. J Biol Chem 279: 18998-19007.
40. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, et al. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22: 5662-5668.
41. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, et al. (1996) DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J 15: 5616-5626.
42. Xu X, Sun YL, Hoey T, (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273: 794-797.
43. Chatterjee-Kishore M, Wright KL, Ting JP, Stark GR, (2000) How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 19: 4111-4122.